Chronic Myeloid Leukemia, Chronic Phase Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
Recruiting
  • Chronic Phase Chronic Myeloid Leukemia
  • Chronic Myeloid Leukemia, Chronic Phase
  • Tampa, Florida
  • +7 more
2022-04-04
Apr 4, 2022
S
Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.
Not yet recruiting
  • Olverembatinib
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
2022-04-04
Apr 4, 2022
S
Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure
Recruiting
  • Flumatinib
  • +2 more
  • Shenzhen, Guangdong, China
    The Second People's Hospital of Shenzhen
2022-03-15
Mar 15, 2022
S
Nilotinib for First-line Newly Diagnosed CML-CP Patients
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
2022-03-15
Mar 15, 2022
F
Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Ponatinib 15 MG
  • Acetylsalicylic acid 100 MG
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +12 more
2022-02-08
Feb 8, 2022
I
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Beijing, China
    Peking University People's Hospital(北京大学人民医院)
2022-01-03
Jan 3, 2022
I
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Radotinib HCl
  • Uijeongbu-si, Gyeonggi-do, Korea, Republic of
  • +17 more
2022-01-03
Jan 3, 2022
A
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Not yet recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
2021-11-23
Nov 23, 2021
M
Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia - 2021
Terminated
  • Chronic Myeloid Leukemia, Chronic Phase
  • Eicosapentaenoic Acid
  • Tyrosine kinase inhibitor
  • Hershey, Pennsylvania
    Penn State Cancer Institute
2021-10-04
Oct 4, 2021
U
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
Active, not recruiting
  • CML, Chronic Phase
  • +4 more
  • Chapel Hill, North Carolina
    UNC Hospital
2021-08-27
Aug 27, 2021
U
Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    2021-08-12
    Aug 12, 2021
    A
    A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, Beijing, China
    • +21 more
    2021-06-25
    Jun 25, 2021
    A
    A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation
    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, Beijing, China
    • +9 more
    2021-05-20
    May 20, 2021
    M
    Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients With Chronic Myeloid Leukemia
    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Withdrawal;Drug
    • Imatinib withdrawal
    • +2 more
    • Brno, Czechia
    • +7 more
    2021-05-05
    May 5, 2021
    A
    Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia - 2019
    Completed
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, Beijing, China
      Peking University People's Hospital
    2020-01-19
    Jan 19, 2020
    S
    Efficacy and Safety of Nilotinib in CML-CP - 2016
    Completed
    • Chronic Myeloid Leukemia, Chronic Phase
    • (no location specified)
    2017-11-01
    Nov 1, 2017
    H
    Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan - 2015
    Completed
    • Chronic Myeloid Leukemia, Chronic Phase
    • Amman, Jordan
    • +2 more
    2016-11-29
    Nov 29, 2016